在体外以MHC受限合成HLA-A2重链与β2-微型血球蛋白,在体外以MHC受限合成
M L Silver1, K C Parker, D C Wiley
1Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, Massachusetts 02138.
Nature
|April 18, 1991
概括
人类白细胞抗原 (HLA) 重链和β2微球蛋白与MHC受限重组. 这种联折叠和组装解释了HLA.
科学领域:
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
- 生物化学 生物化学
背景情况:
- 细胞毒性T淋巴细胞 (CTLs) 识别由人类白细胞抗原 (HLA) 类I分子呈现的病毒抗原.
- 晶体结构显示抗原是HLA结构的组成部分,位于槽中.
- 了解HLA组装对于免疫反应机制至关重要.
研究的目的:
- 调查在重链HLA-A2和β2-微球蛋白的重新折叠和组装中的作用.
- 为了确定MHC受限制的是否对于高效的HLA-A2复合体形成是必要的.
主要方法:
- 在变质剂中分离和分离HLA-A2重链和β2-微球蛋白.
- 在各种的存在下,分离组件的改性化.
- 使用生物化学测试分析复杂的形成.
- 复制的HLA-A2 / 复合物的结晶.
主要成果:
- HLA-A2重链和β2-微球蛋白只能与MHC受限制的有效地重组.
- 一个1:1:1的重链,β2-微球蛋白和病毒的复合体形成,产量高达46%.
- 没有观察到与非受限制的复制.
- 复制的HLA-A2 / 流感核蛋白复合物容易结晶.
结论:
- 结合对于HLA-A2.2的正确折叠和组装至关重要.
- 这种结组装机制可能有助于HLA的广泛结能力.
- 结果提供了对抗原呈现的结构基础的见解.
相关概念视频
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...


